Global Hematology Analyzers Market Size By Product And Services (Instruments, Reagents & Consumables, Services), By End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories), By Geographic Scope And Forecast

Hematology Analyzers Market Size And Forecast

Hematology Analyzers Market size was valued at USD 7.50 Billion in 2020 and is projected to reach USD 12.39 Billion by 2028, growing at a CAGR of 6.37% from 2021 to 2028. 

The Global Hematology Analyzers Market is growing due to the increasing prevalence of blood-related disorders. Hematology technology is still in its infancy in the world of healthcare, but it has come a long way in terms of application and usability. Blood samples are analyzed using hematology analyzers, which count white blood cells and perform reticulocyte analysis. The Global Hematology Analyzers Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Hematology Analyzers Market Definition

Hematology analyzers are basically machines that run a complete blood test – you know, the kind you usually get during a check-up? Nowadays, most of these analyzers do a bit extrathey can give you a reticulocyte count right along with your regular blood count. This not only tells you the percentage and total number of reticulocytes, but also gives you other useful info like reticulocyte hemoglobin content (CHr), the percentage of cells that are hypochromic (meaning they don't have enough hemoglobin), the percentage of microcytic cells or even a microcytic anemia factor, plus the immature reticulocyte fraction, and more! That CHr thing? It's actually a measure of how much hemoglobin is packed into a reticulocyte, measured in picograms (pg), and it tells you how well your red blood cells are "globalizing" (basically, maturing).

Hey, so the NCBI (that's the National Center for Biotechnology Information) says that CHr is a pretty handy way to see if you've got enough usable iron kicking around for making red blood cells in the last 3-4 days. Turns out, CHr is really good at spotting iron deficiency messing with red blood cell production. If your CHr is like, 27 pg, that strongly suggests you might have anemia because of low iron. Also, checking out the percent of hypochromic red cells (that's the percentage with low hemoglobin – less than 28 g/dl on Siemens and Advia, or less than 17 pg on Sysmex) is a sensitive way to figure out how mature red cells are distributing hemoglobin.

If over 10% of your red blood cells are hypochromic (meaning they're paler than they should be), it's a strong sign you might have iron deficiency anemia. Modern blood analyzers are pretty sophisticated! They give us a really detailed look at your white blood cells – a five- to seven-part breakdown – using things like electrical impedance, radiofrequency conductivity, how light scatters off the cells, fluorescence, and even some cytochemistry. Plus, they offer even more insights, like statistics on the cell populations, the Lymph Index Granularity Index, and can even flag potentially problematic large unstained cells or hemoparasites. This extra information can help us screen for both harmless and serious blood disorders. And, get this, for each different type of white blood cell, a thing called CPD is created during the white-cell analysis using something called VCS technology.

Following the lysis of red cells, the Coulter hematology analyzer’s VCS technology can obtain data from >8000 white blood cells in their near-native state in a few seconds, using impedance to measure cell volume for accurate size of all cell types, radiofrequency opacity to characterize conductivity for inner composition-nuclear volume, nuclear-cytoplasmic details of each cell and nuclear lobulations, and a beam to measure light scatter for cytoplasmic.

Global Hematology Analyzers Market Overview

More and more people are donating blood, which is great! But sadly, we're also seeing more folks with blood disorders, which is also driving up demand for related products. We think this trend will really push the market forward. Plus, these products are often used with flow cytometry, and that's helping things grow too. Automated analyzers have really sped up testing and made everything way more efficient. And with conditions like anemia and leukemia on the rise, we expect even more growth. Finally, with rising disposable incomes around the world, people are spending more on healthcare, which is boosting the market as well.

We're seeing a big boom in commercial testing centers, and that's largely because we can now test so much more! What's fueling this? Well, people have more money to spend, we're seeing more cases of diseases like Leukemia, and honestly, the technology is just getting better. Think about itwe now have fully automated hematology analyzers that can do 3-part and 5-part analyses – they're practically self-contained labs! And while the 3-part analyzer is a bit cheaper, all this tech is making things easier. Plus, governments are putting more money into healthcare, trying to make the system stronger, which means more new testing centers popping up. But it's not all sunshine and roses. The high cost of those fancy hematology analyzers, along with those strict reimbursement rules, could slow things down a bit.

Because hematology analyzers can really hit the wallet hard, especially for small and mid-sized businesses, it can be a real challenge. Plus, many insurance companies have been making it harder to get reimbursed, which means some people just can't afford to get the medical care they need. This is expected to slow down growth in the field. Now, on a different note, let's talk about how a three-part differential cell counter works. It uses something called Coulter's Principle to figure out the size and volume of a cell. Basically, the sample gets broken down (lysed) and mixed into an electrolyte solution inside a container, which is inside another container. These 3-part hematology analyzer systems are great for moderately complex testing in places like doctor's offices, clinics, and smaller hospitals. And while 5-part hematology analyzers are becoming more common, 3-part analyzers are often a more cost-effective choice for those regular hematological examinations.

Clinical laboratories, the places that actually use hematological tests, are usually called end-users. They tend to have really good equipment, so the results you get are generally pretty trustworthy. Now, automating these labs has definitely made the equipment more expensive, but you'd be surprised how often labs skip upgrading their analyzers. These labs test all sorts of things – whole blood, serum, urine, cerebrospinal fluid, you name it! And, for example, following guidelines from the CDC (Centers for Disease Control and Prevention), blood pressure is often measured using an Omron IntelliSense Blood Pressure Monitor (ModelHEM-907XL). This Omron BP monitor is specifically designed to give accurate blood pressure and pulse rate readings quickly in a clinical setting.

Global Hematology Analyzers Market Segmentation Analysis

The Global Hematology Analyzers Market Is Segmented On The Basis Of Product And Services, End User, and Geography.

Hematology Analyzers Market, By Product And Services

• Instruments• Reagents & Consumables• Services

Based on Product And Services, the market is segmented into Instruments, Reagents & Consumables, and Services. Instruments are further divided into 5- and 6-part Fully Automated Hematology Analyzers, 3-part Completely Automated Hematology Analyzers, Point-of-Care Testing Hematology Analyzers, and Moderately Hematology Analyzers under the Instruments section. Hematology Reagents, Side Stainers/Makers, Controls and Calibrators, and Consumables make up the Reagents & Consumables section. All of the segments are expected to increase significantly.

This is due to the growing popularity of these instruments around the world. Blood samples are tested using hematology analyzers. White blood cell counts, complete blood counts, reticulocyte analysis, and coagulation tests are all done with them in the medical sector. Animals and human blood hematology analyzers are accessible, making them suitable for veterinarians, zoos, and research organizations. Closed vial testing and open sampling testing are two features that differ from one hematological analyzer to the next.

Hematology Analyzers Market, By End User

• Hospital Laboratories• Commercial Service Providers• Government Reference Laboratories• Research & Academic Institutes

Okay, so depending on who's actually using the stuff, we're dividing the market into a few groupsHospital Laboratories, Commercial Service Providers, Government Reference Laboratories, and of course Research & Academic Institutes. Think about ityou've got all those automated analyzers humming away in a hospital lab. And just to clarify, a medical lab – sometimes called a clinical lab – is where they run tests on samples from patients to figure out what's going on with their health, help doctors treat them, and try to keep them from getting sick in the first place. But guess what? We're expecting the Commercial Service Provider group to really dominate. Why? Well, we're seeing more cases of diseases like leukemia, and more labs are switching over from doing things by hand to using automated systems. Plus, those commercial providers often have some extra bells and whistles that you might not find in a hospital lab. They often provide additional benefits and advantages, you know?

Hematology Analyzers Market, By Geography

• North America• Europe• Asia Pacific• Rest of the world

On the basis of Geography, the Global Hematology Analyzers Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The Asia Pacific region is expected to show positive growth during the forecast period. This is primarily due to the increasing prevalence of blood-related disorders. Hematology technology is still in its infancy in the world of healthcare, but it has come a long way in terms of application and usability. Blood samples are analyzed using hematology analyzers, which count white blood cells and perform reticulocyte analysis.

Key Players

The “Global Hematology Analyzers Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories, Boule Diagnostics AB, Hoffmann-La Roche Ltd, Horiba Ltd., Nihon Kohden Corporation, Mindray Medical International Limited, Siemens Healthineers, and Sysmex Corporation. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• February 2018, McKesson and Sysmex have signed a distribution deal for Sysmex’s XW-100 automated hematology analyzers in the United States.

• February 2021, Beckman Coulter has announced the availability of the DxH 560 AL, a tabletop hematology analyzer.

• April 2, 2020, Siemens Healthineers revealed that the FDA has approved the RapidPoint 500e Blood Gas Analyzer.

• Dec 21, 2020, Nihon Kohden has released MEK-1305 Celltac+, an Automated Hematology, and ESR Analyzer, in the international markets

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

We'll dig into the market using both qualitative and quantitative methods, breaking it down by segments based on money stuff, and well, stuff that isn't about money. You'll get the market value (in USD Billion, no less!) for each of those segments and sub-segments. We'll point out which region and segment is likely to be the rocket ship, seeing the fastest growth and becoming the top dog. Plus, we'll analyze each geographic area, looking at who's buying what and what's influencing the market there. Expect a competitive overview too, including rankings of the big players and details on new services and product launches, partnerships, expansions, and acquisitions from the last five years. We'll provide detailed profiles of the major companies, with company overviews, insights, product comparisons, and SWOT analyses. You'll also get a look at where the industry is now and where it's headed, considering recent developments, growth opportunities, and the challenges in both new and established regions. We'll even dive into the market's different angles with Porter's five forces analysis, offer a peek into the Value Chain, and explore the market's dynamics and future growth possibilities. And to top it off, you get 6 months of analyst support after the sale to help you make the most of it all.

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.